Home LiteratureArticle Details
PMID: 12598611 Published · ppublish English Journal Article

Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.

Gao HM, Hong JS, Zhang W, Liu B

Abstract

Parkinson's disease (PD) is characterized by a progressive degeneration of the nigrostriatal dopaminergic pathway resulting in movement disorders. Although its etiology remains unknown, PD may be the final outcome of interactions among multiple factors, including exposure to environmental toxins and the occurrence of inflammation in the brain. In this study, using primary mesencephalic cultures, we observed that nontoxic or minimally toxic concentrations of the pesticide rotenone (0.5 nm) and the inflammogen lipopolysaccharide (LPS) (0.5 ng/ml) synergistically induced dopaminergic neurodegeneration. The synergistic neurotoxicity of rotenone and LPS was observed when the two agents were applied either simultaneously or in tandem. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species appeared to be a key contributor to the synergistic dopaminergic neurotoxicity. This conclusion was based on the following observations. First, inhibition of NADPH oxidase or scavenging of free radicals afforded significant neuroprotection. Second, rotenone and LPS synergistically stimulated the NADPH oxidase-mediated release of the superoxide free radical. Third and most importantly, rotenone and LPS failed to induce the synergistic neurotoxicity as well as the production of superoxide in cultures from NADPH oxidase-deficient animals. This is the first demonstration that low concentrations of a pesticide and an inflammogen work in synergy to induce a selective degeneration of dopaminergic neurons. Findings from this study may be highly relevant to the elucidation of the multifactorial etiology of PD and the discovery of effective therapeutic agents for the treatment of the disease.

MeSH Terms
Animals Cells, Cultured Dopamine Drug Synergism Inflammation Mediators/toxicity Insecticides/toxicity Lipopolysaccharides/toxicity Membrane Glycoproteins/genetics Mesencephalon/cytology Mice Mice, Inbred C57BL Mice, Knockout Microglia/enzymology NADPH Oxidase 2 NADPH Oxidases/metabolism Nerve Degeneration/chemically induced Neurons/cytology,drug effects,metabolism Parkinson Disease/etiology,pathology Rats Rats, Inbred F344 Rotenone/toxicity Superoxides/metabolism
Chemicals
Inflammation Mediators Insecticides Lipopolysaccharides Membrane Glycoproteins Rotenone Superoxides CYBB protein, human NADPH Oxidase 2 NADPH Oxidases Dopamine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gao Hui-Ming
Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences/National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Hong Jau-Shyong
Zhang Wanqin
Liu Bin
References (41)
41 references, click to expand
  1. NADPH oxidase: an update.
    Blood. 1999 Mar 1;93(5):1464-76 PMID: 10029572
  2. Etiology and pathogenesis of Parkinson's disease.
    Annu Rev Neurosci. 1999;22:123-44 PMID: 10202534
  3. Microglia as mediators of inflammatory and degenerative diseases.
    Annu Rev Neurosci. 1999;22:219-40 PMID: 10202538
  4. FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
    J Neurosci. 1999 May 1;19(9):3440-7 PMID: 10212304
  5. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons.
    J Neurosci. 2000 Jan 1;20(1):RC53 PMID: 10627630
  6. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.
    J Pharmacol Exp Ther. 2000 May;293(2):607-17 PMID: 10773035
  7. Parkinson's disease mortality and pesticide exposure in California 1984-1994.
    Int J Epidemiol. 2000 Apr;29(2):323-9 PMID: 10817132
  8. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.
    J Neurosci. 2000 Aug 15;20(16):6309-16 PMID: 10934283
  9. Mitochondrial dysfunction in Parkinson's disease.
    Biochem Soc Symp. 1999;66:85-97 PMID: 10989660
  10. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias.
    Neurology. 2000 Oct 24;55(8):1158-66 PMID: 11071494
  11. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes.
    J Neurosci. 2000 Dec 1;20(23):RC111 PMID: 11090611
  12. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
    Nat Neurosci. 2000 Dec;3(12):1301-6 PMID: 11100151
  13. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
    J Neurosci. 2000 Dec 15;20(24):9207-14 PMID: 11124998
  14. Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management.
    Altern Med Rev. 2000 Dec;5(6):502-29 PMID: 11134975
  15. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity.
    Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1643-8 PMID: 11172004
  16. Changes in cytokines and neurotrophins in Parkinson's disease.
    J Neural Transm Suppl. 2000;(60):277-90 PMID: 11205147
  17. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis.
    J Neurochem. 2001 Apr;77(1):182-9 PMID: 11279274
  18. A case-control study of Parkinson's disease in urban population of southern Israel.
    Can J Neurol Sci. 2001 May;28(2):144-7 PMID: 11383940
  19. Environmental risk factors and Parkinson's disease: a metaanalysis.
    Environ Res. 2001 Jun;86(2):122-7 PMID: 11437458
  20. Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity.
    Stroke. 2001 Oct;32(10):2370-5 PMID: 11588328
  21. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.
    J Neurosci. 2002 Feb 1;22(3):782-90 PMID: 11826108
  22. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.
    Mov Disord. 2002 Jan;17(1):116-24 PMID: 11835448
  23. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia.
    J Neurosci. 2002 May 1;22(9):3484-92 PMID: 11978825
  24. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.
    J Neurochem. 2002 Jun;81(6):1285-97 PMID: 12068076
  25. Role of nitric oxide in inflammation-mediated neurodegeneration.
    Ann N Y Acad Sci. 2002 May;962:318-31 PMID: 12076984
  26. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.
    J Pharmacol Exp Ther. 2003 Jan;304(1):1-7 PMID: 12490568
  27. Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis.
    Neurology. 1991 Oct;41(10):1554-7 PMID: 1922795
  28. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.
    Neuroscience. 1990;39(1):151-70 PMID: 2089275
  29. 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles.
    Biochem Biophys Res Commun. 1990 Aug 16;170(3):1049-55 PMID: 2167668
  30. Trauma as an etiology of parkinsonism: a historical review of the concept.
    Mov Disord. 1988;3(1):30-6 PMID: 3050470
  31. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
    Neurology. 1988 Aug;38(8):1285-91 PMID: 3399080
  32. Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis.
    J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):753-6 PMID: 3404182
  33. 1918 influenza, encephalitis lethargica, parkinsonism.
    Lancet. 1982 Oct 16;2(8303):860-4 PMID: 6126720
  34. ALS, SOD and peroxynitrite.
    Nature. 1993 Aug 12;364(6438):584 PMID: 8350919
  35. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures.
    Brain Res. 1995 Dec 15;704(1):112-6 PMID: 8750970
  36. Microglia: a sensor for pathological events in the CNS.
    Trends Neurosci. 1996 Aug;19(8):312-8 PMID: 8843599
  37. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease.
    Biochim Biophys Acta. 1997 Nov 28;1362(1):77-86 PMID: 9434102
  38. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease.
    Brain Res. 1998 Jan 12;780(2):294-303 PMID: 9507169
  39. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living.
    Neurology. 1998 May;50(5):1346-50 PMID: 9595985
  40. Understanding cell death in Parkinson's disease.
    Ann Neurol. 1998 Sep;44(3 Suppl 1):S72-84 PMID: 9749577
  41. Postencephalitic parkinsonism--a review.
    J Neural Transm (Vienna). 1998;105(6-7):645-76 PMID: 9826109
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2003-02-15
Pages
1228-36
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6742266
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com